Browsing by Author "Okur, Emrah"

Now showing items 1-3 of 3

Data for a proteomic analysis of p53-independent induction of apoptosis by bortezomib

Yerlikaya, Azmi; Okur, Emrah; Baykal, Ahmet Tarık; Acılan, Ceyda; Boyacı, İhsan; Ulukaya, Engin (Elsevier, 2014)

This data article contains data related to the research article entitled, "A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line" by Yerlikaya et al. [1]. The research ...
Differential effects of p38 MAP kinase inhibitors SB203580 and SB202190 on growth and migration of human MDA-MB-231 cancer cell line

Düzgün, Şükrü Aydın; Yerlikaya, Azmi; Zeren, Sezgin; Bayhan, Zülfü; Okur, Emrah; Boyacı, İhsan (Springer, 2017)

p38 mitogen-activated protein kinase (MAPK) belongs to the MAPK superfamily, phosphorylating serine and/or threonine residues of the target proteins. The activation of p38 MAPK leads to cell growth, differentiation, ...
A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line

Yerlikaya, Azmi; Okur, Emrah; Baykal, Ahmet Tarık; Acılan, Ceyda; Boyacı, İhsan; Ulukaya, Engin (Elsevier Science, 2015)

The 26S proteasome is a proteolytic enzyme found in both cytoplasm and nucleus. In this study, we examined the differential expression of proteasome inhibitor bortezomib-induced proteins in p53-deficient 4T1 cells. It was ...